The year's adjusted EBITDA of 89,900,000 is $112,800,000 higher than twenty twenty three's, adjusted EBITDA loss of $22,900,000 and very close to our most recently communicated expectation for 2024 of $90,000,000 As a reminder, we define adjusted EBITDA as net income or loss before interest, taxes, depreciation, amortization, stock based compensation expenses and other items that we do not believe are indicative of our core operating performance. In Q4, these adjustments were limited to $2,500,000 of stock based compensation, dollars 5,400,000.0 of depreciation, $3,500,000 of net interest expenses and $200,000 of net income tax expenses. Positive net income in Q4 of $11,400,000 or $0.14 per diluted share, assuming 82,990,000.00 shares, contributed to the year's positive net income of $13,400,000 or $0.17 per share on 80,300,000.0 shares. Next, I'll turn to cash flow and our balance sheet. We generated positive free cash flow of $20,900,000 in Q4 by freeing up $14,600,000 working capital and funding CapEx of only $14,800,000 7 point 4 million dollars of this CapEx funded Plant 2 in Statesboro, Georgia, while the remainder funded projects at our aerogel plant in Rhode Island and additional assembly equipment for new OEM programs at our EV thermal barrier assembly facility in Mexico.